ES262116A1 - Method for the preparing a solution of aspirin for injection and product obtained thereby - Google Patents

Method for the preparing a solution of aspirin for injection and product obtained thereby

Info

Publication number
ES262116A1
ES262116A1 ES0262116A ES262116A ES262116A1 ES 262116 A1 ES262116 A1 ES 262116A1 ES 0262116 A ES0262116 A ES 0262116A ES 262116 A ES262116 A ES 262116A ES 262116 A1 ES262116 A1 ES 262116A1
Authority
ES
Spain
Prior art keywords
acetylsalicylic acid
aspirin
preparing
injection
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0262116A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VAN MOORLEGHEM GUY LEOPOLD
Original Assignee
VAN MOORLEGHEM GUY LEOPOLD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VAN MOORLEGHEM GUY LEOPOLD filed Critical VAN MOORLEGHEM GUY LEOPOLD
Publication of ES262116A1 publication Critical patent/ES262116A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An injectable aqueous solution of acetylsalicylic acid is prepared by placing acetylsalicylic acid powder inside a fluid tightly closed phial, sterilizing by means of a linear electron accelerator of a power of substantially 4 meV. and, immediately prior to use, the sterile acetylsalicylic acid is dissolved in a sterile aqueous solution of sodium citrate in pyrogen-free water under aseptic conditions.
ES0262116A 1959-11-02 1960-10-31 Method for the preparing a solution of aspirin for injection and product obtained thereby Expired ES262116A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR39865 1959-11-02

Publications (1)

Publication Number Publication Date
ES262116A1 true ES262116A1 (en) 1961-03-01

Family

ID=8593488

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0262116A Expired ES262116A1 (en) 1959-11-02 1960-10-31 Method for the preparing a solution of aspirin for injection and product obtained thereby

Country Status (2)

Country Link
ES (1) ES262116A1 (en)
GB (1) GB912894A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3474858B1 (en) * 2016-06-28 2021-08-18 Asamedic AS Two-component composition comprising acetylsalicylic acid

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018222583A1 (en) 2017-05-30 2018-12-06 Rho Pharmaceuticals, Llc In-vial deposition of a stable, sterile and crystalline o-acetyl salicylic acid (aspirin)
EP3501523A1 (en) 2017-12-22 2019-06-26 Asamedic AS Two-component compositions comprising acetyl salicylic acid and a carbonate salt
EP3501522A1 (en) 2017-12-22 2019-06-26 Asamedic AS Compositions comprising acetylsalicylic acid and a phosphate salt

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3474858B1 (en) * 2016-06-28 2021-08-18 Asamedic AS Two-component composition comprising acetylsalicylic acid
EP3871677A1 (en) * 2016-06-28 2021-09-01 Asamedic AS Two-component composition comprising acetylsalicylic acid

Also Published As

Publication number Publication date
GB912894A (en) 1962-12-12

Similar Documents

Publication Publication Date Title
GB1056331A (en) Process for preparing glucosamine salts
ES262116A1 (en) Method for the preparing a solution of aspirin for injection and product obtained thereby
Kaplan Third generation follow-up of women treated by X-ray therapy for menstrual dysfunction and sterility twenty-eight years ago, with detailed histories of the grandchildren born to these women
ES292339A1 (en) Procedure for sterilization or pasteurization of the inside of containers in plastic material (Machine-translation by Google Translate, not legally binding)
GB842222A (en) Colour radiography
ES389874A1 (en) Apparatus for sterilizing compressed air
ES331182A1 (en) A procedure for the preparation of epsilon-caprolactone and its alcohol derivatives. (Machine-translation by Google Translate, not legally binding)
GB2120529A (en) Methods of preparing and using intravenous nutrient compositions
GB1083700A (en) Method of sterilising objects by use of steam
GB942797A (en) Production of quinacridones
ES253248A1 (en) Procedure for obtaining special medicinal products (Machine-translation by Google Translate, not legally binding)
GB1034985A (en) Process for the production of vitamin b
GB1035602A (en) Treatment of polymeric fat acids
GB848051A (en) Therapeutic product
ES272242A3 (en) A procedure for the preparation of betaine salts (Machine-translation by Google Translate, not legally binding)
ES378547A1 (en) Procedure for the obtaining of 2,5-dimethyl-1,3,4,9 b- tetrahydro-2H-indeno (1,2-c) pyridine. (Machine-translation by Google Translate, not legally binding)
GB1001605A (en) A pharmaceutical composition for the treatment of cyanide poisioning
GB1027058A (en) Dispersions of anaesthetics for injection
GR24738B (en) METHOD FOR THE PREPARATION OF THERAPEUTIC BENEFITS OF UNSATURATED FATTY ACID COMPOUNDS.
GB880445A (en) Improvements relating to the heat treatment of material
GB1009144A (en) Cephalosporin derivatives
ES356078A1 (en) Method of Manufacture of Complex Compounds of Ferric Iron with Hydrogenated Dextran and of Complex Compounds of Ferric Iron with Hydrogenated Dextran and Sodium Citrate or Citric Acid.
GB822595A (en) 17-a-methyl-17-hydroxy-5(10)-estren-3-one
ES254158A1 (en) Procedure for preparing phosphate layers on iron (Machine-translation by Google Translate, not legally binding)
GB815567A (en) Method of preparing 3-methyl-3-carboxy-cyclohexanone-(1)-2ª‰-propionic acid and derivatives thereof